| http://www.w3.org/ns/prov#value | - The basis for the SG's arguments came almost exclusively from the Court's reasoning in the Merck decision, which held that any use of a patented invention for developing information that could be submitted to the FDA or other regulatory agency to obtain marketing approval falls within the scope of the safe harbor.
|
